OGI - Organigram Global Inc.
NEXT EARNINGS:
Apr 14, 2026
EPS Est: $-0.01
|
Rev Est: $52.4M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
Market Cap:
191.89M
Volume:
555,272
Avg Volume:
1,155,416
52 Week Range:
0.85-2.24
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
2.09
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
CA
Employees:
1,093
IPO Date:
2019-05-21
EPS (TTM):
-0.14
P/E Ratio:
-20.29
Revenue (TTM):
186.09M
Total Assets:
562.21M
Total Debt:
8.75M
Cash & Equiv:
28.20M
Rev Growth (5Y):
16.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-6.3%
Debt/Equity:
0.03
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-10 | $-0.02 | $-0.01 | -100.0% | $46.2M | $71.3M | -35.1% |
| 2025-12-16 | $-0.20 | $-0.01 | -1900.0% | $57.4M | $69.7M | -17.7% |
| 2025-08-13 | $-0.03 | $-0.01 | -200.0% | $52.0M | $73.0M | -28.8% |
| 2025-05-12 | $-0.05 | $-0.03 | -66.7% | $46.1M | $65.3M | -29.5% |
| 2025-02-11 | $-0.05 | $-0.03 | -66.7% | $29.7M | $65.3M | -54.5% |
| 2024-12-18 | $-0.04 | $-0.03 | -33.3% | $33.1M | $52.2M | -36.6% |
| 2024-08-13 | $0.02 | $-0.05 | +140.0% | $30.0M | $32.2M | -6.8% |
| 2024-05-14 | $-0.12 | $-0.06 | -100.0% | $27.7M | $118.1M | -76.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 186.09M | 159.84M | 149.21M | 145.81M | 79.16M | 86.80M | 80.41M | 12.43M | 5.39M | 6.13M | 986,676 | 0 |
| Net Income | (17.78M) | (45.44M) | (229.48M) | (14.28M) | (130.70M) | (136.16M) | (9.54M) | 20.51M | (10.89M) | 846,663 | (1.28M) | (239,000) |
| EPS | -0.14 | -0.48 | -2.82 | -0.18 | -2.04 | -3.15 | -0.27 | 0.68 | -0.45 | 0.06 | -0.10 | -0.12 |
| Total Assets | 562.21M | 407.86M | 298.45M | 577.11M | 554.02M | 417.62M | 428.52M | 302.57M | 92.81M | 53.87M | 14.18M | 139,937 |
| Total Debt | 8.75M | 4.46M | 3.71M | 3.36M | 5.95M | 103.67M | 49.58M | 99.16M | 3.52M | 7.49M | 4.86M | 0 |
| Cash & Equivalents | 28.20M | 106.75M | 33.86M | 68.52M | 55.37M | 24.60M | 47.55M | 55.06M | 1.96M | 9.86M | 1.47M | 136,997 |
| Operating Cash Flow | (4.30M) | 3.87M | (35.80M) | (36.21M) | (28.59M) | (45.12M) | (35.08M) | (12.70M) | (6.11M) | (1.77M) | (2.77M) | 9,217 |
| Free Cash Flow | (16.52M) | (1.47M) | (62.70M) | (84.99M) | (40.92M) | (123.78M) | (145.38M) | (69.14M) | (40.44M) | (6.19M) | (10.30M) | (20,783) |
| FCF per Share | -0.13 | -0.02 | -0.77 | -1.06 | -0.64 | -2.87 | -4.13 | -2.29 | -1.66 | -0.42 | -0.79 | -0.01 |
| Book Value | 349.13M | 305.99M | 271.62M | 508.06M | 479.81M | 299.53M | 327.01M | 184.59M | 83.03M | 44.26M | 7.85M | 24,495 |
| Cash & ST Investments | 29.03M | 107.57M | 33.86M | 98.91M | 183.84M | 74.73M | 47.94M | 130.06M | 33.96M | 32.63M | 1.47M | 136,997 |
| ROC Equity | -0.05 | -0.15 | -0.84 | -0.03 | -0.27 | -0.45 | -0.03 | 0.11 | -0.13 | 0.02 | -0.16 | -9.76 |